Samrat Pharmachem Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

310.65

221.81

179.02

137.45

111.14

Operating profit

23.93

24.34

8.67

6.63

3.18

Interest

1.23

0.67

1.28

0.98

1.06

Gross profit

23.17

24.22

7.85

6.22

2.58

EPS (Rs)

53.83

55.62

17.26

13.71

4.97

Other income

0.48

0.55

0.46

0.57

0.46

Stock adjustment

-10.14

-0.33

2.23

-6.18

-0.91

Raw material

288.00

190.23

162.02

131.80

103.53

Power and fuel

-

-

-

-

-

Employee expenses

1.88

1.77

1.50

1.44

1.38

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

6.97

5.79

4.61

3.76

3.95

Provisions made

-

-

-

-

-

Depreciation

0.64

0.59

0.49

0.43

0.42

Taxation

5.90

6.42

2.01

1.55

0.62

Net profit / loss

16.63

17.18

5.33

4.24

1.54

Extra ordinary item

-

-0.02

-0.02

-0.01

-

Prior year adjustments

-

-

-

-

-

Equity capital

3.09

3.09

3.09

3.09

3.09

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

7.70

10.97

4.84

4.82

2.86

GPM (%)

7.45

10.89

4.38

4.51

2.31

NPM (%)

5.35

7.73

2.97

3.07

1.38